Brief: Piramal Pharma Says US FDA Inspection At Piramal Pharma's Manufacturing Facility Located At Lexington, USA
23/05/2024 07:02
May 23 (Reuters) - Piramal Pharma Ltd PIRM.NS :
* US FDA INSPECTION AT PIRAMAL PHARMA'S MANUFACTURING
FACILITY
LOCATED AT LEXINGTON, USA
* US FDA HAS ISSUED ESTABLISHMENT INSPECTION REPORT FOR
MANUFACTURING FACILITY
* INSPECTION HAS NOW BEEN SUCCESSFULLY CLOSED BY US FDA
Source text for Eikon: ID:nBSE5516l4
Further company coverage: PIRM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington